GSE212057 SIRT6 overexpression 2 v 7 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE212057_SIRT6 overexpression_2_v_7_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE212057_SIRT6 overexpression_2_v_7_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE212057_SIRT6 overexpression_2_v_7_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE212057_SIRT6 overexpression_2_v_7_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

tripartite motif containing 16 like (pseudogene)

Gene

GOLGA2 pseudogene 7

Gene

ARPIN-AP3S2 readthrough

Gene

long intergenic non-protein coding RNA 511

Gene

BAIAP2 divergent transcript

Gene

dehydrogenase/reductase X-linked

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

MIR34A host gene

  • Gene

    DExD-box helicase 52


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    ARPIN-AP3S2 readthrough


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    BAIAP2 divergent transcript


  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.